Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Carr

Showing results (531-540 of 545) with videos related to

Pageof 55
Sort By:
American Journal of Physiology. Lung Cellular and Molecular Physiology|October 26, 2018
Divergent changes of p53 in pulmonary arterial endothelial and smooth muscle cells involved in the development of pulmonary hypertensionZiyi Wang, Kai Yang, Qiuyu Zheng, et al.
Journal of Medical Genetics|March 30, 2021
Testicular Sertoli cell tumour and potentially testicular Leydig cell tumour are features of <i>DICER1</i> syndromeLisa Golmard, Lauren M Vasta, Valérie Duflos, et al.
Pulmonary Circulation|December 9, 2020
Endothelial platelet-derived growth factor-mediated activation of smooth muscle platelet-derived growth factor receptors in pulmonary arterial hypertensionKang Wu, Haiyang Tang, Ruizhu Lin, et al.
Medical Image Analysis|May 28, 2013
Benchmarking framework for myocardial tracking and deformation algorithms: an open access databaseC Tobon-Gomez, M De Craene, K McLeod, et al.
Journal of Medicinal Chemistry|January 16, 2009
Fragment-based discovery of the pyrazol-4-yl urea (AT9283), a multitargeted kinase inhibitor with potent aurora kinase activitySteven Howard, Valerio Berdini, John A Boulstridge, et al.
JAMA Network Open|November 1, 2024
State and National Estimates of the Cost of Emergency Department Pediatric Readiness and Lives SavedCraig D Newgard, Amber Lin, Jeremy D Goldhaber-Fiebert, et al.
Mayo Clinic Proceedings. Digital Health|December 3, 2025
Identifying Bias at Scale in Clinical Notes Using Large Language ModelsDonald U Apakama, Kim-Anh-Nhi Nguyen, Daphnee Hyppolite, et al.
Journal of Medicinal Chemistry|July 29, 2010
Discovery of (2,4-dihydroxy-5-isopropylphenyl)-[5-(4-methylpiperazin-1-ylmethyl)-1,3-dihydroisoindol-2-yl]methanone (AT13387), a novel inhibitor of the molecular chaperone Hsp90 by fragment based drug designAndrew J Woodhead, Hayley Angove, Maria G Carr, et al.
Antiviral Chemistry & Chemotherapy|November 26, 1999
The design and synthesis of potent inhibitors of hepatitis C virus NS3-4A proteinaseM R Attwood, J M Bennett, A D Campbell, et al.
Journal of Medicinal Chemistry|July 29, 2008
Identification of N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H-pyrazole-3-carboxamide (AT7519), a novel cyclin dependent kinase inhibitor using fragment-based X-ray crystallography and structure based drug designPaul G Wyatt, Andrew J Woodhead, Valerio Berdini, et al.
Pageof 55

Showing results (531-540 of 545) with videos related to

Sort By:
Pageof 55
American Journal of Physiology. Lung Cellular and Molecular Physiology|October 26, 2018
Divergent changes of p53 in pulmonary arterial endothelial and smooth muscle cells involved in the development of pulmonary hypertensionZiyi Wang, Kai Yang, Qiuyu Zheng, et al.
Journal of Medical Genetics|March 30, 2021
Testicular Sertoli cell tumour and potentially testicular Leydig cell tumour are features of <i>DICER1</i> syndromeLisa Golmard, Lauren M Vasta, Valérie Duflos, et al.
Pulmonary Circulation|December 9, 2020
Endothelial platelet-derived growth factor-mediated activation of smooth muscle platelet-derived growth factor receptors in pulmonary arterial hypertensionKang Wu, Haiyang Tang, Ruizhu Lin, et al.
Medical Image Analysis|May 28, 2013
Benchmarking framework for myocardial tracking and deformation algorithms: an open access databaseC Tobon-Gomez, M De Craene, K McLeod, et al.
Journal of Medicinal Chemistry|January 16, 2009
Fragment-based discovery of the pyrazol-4-yl urea (AT9283), a multitargeted kinase inhibitor with potent aurora kinase activitySteven Howard, Valerio Berdini, John A Boulstridge, et al.
JAMA Network Open|November 1, 2024
State and National Estimates of the Cost of Emergency Department Pediatric Readiness and Lives SavedCraig D Newgard, Amber Lin, Jeremy D Goldhaber-Fiebert, et al.
Mayo Clinic Proceedings. Digital Health|December 3, 2025
Identifying Bias at Scale in Clinical Notes Using Large Language ModelsDonald U Apakama, Kim-Anh-Nhi Nguyen, Daphnee Hyppolite, et al.
Journal of Medicinal Chemistry|July 29, 2010
Discovery of (2,4-dihydroxy-5-isopropylphenyl)-[5-(4-methylpiperazin-1-ylmethyl)-1,3-dihydroisoindol-2-yl]methanone (AT13387), a novel inhibitor of the molecular chaperone Hsp90 by fragment based drug designAndrew J Woodhead, Hayley Angove, Maria G Carr, et al.
Antiviral Chemistry & Chemotherapy|November 26, 1999
The design and synthesis of potent inhibitors of hepatitis C virus NS3-4A proteinaseM R Attwood, J M Bennett, A D Campbell, et al.
Journal of Medicinal Chemistry|July 29, 2008
Identification of N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H-pyrazole-3-carboxamide (AT7519), a novel cyclin dependent kinase inhibitor using fragment-based X-ray crystallography and structure based drug designPaul G Wyatt, Andrew J Woodhead, Valerio Berdini, et al.
Pageof 55